pAAV2-CAG-3xNLS-vsfGFP-0
(Plasmid
#191097)
-
PurposeTo express a bright green nanobody FP to label eucaryotic cell nuclei. To be used in tissue clearing methods and other fluorescent microscopy methods
-
Depositing Labs
-
Sequence Information
-
Sequences (1) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 191097 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepAAV2-CAG
-
Backbone manufacturerOriginal was from the Boyden laboratory
- Backbone size w/o insert (bp) 4714
- Total vector size (bp) 5860
-
Vector typeMammalian Expression, AAV
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert name3xNLS-vsfGFP-0
-
SpeciesSynthetic
-
Insert Size (bp)1149
-
MutationOptimized to Human codon usage
- Promoter CMV and CAG
-
Tag
/ Fusion Protein
- Green fluorescent protein bound to enhancer nanobody [Camelus dromedarius] Sequence ID: 3K1K_C (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (destroyed during cloning)
- 3′ cloning site EcoRV (destroyed during cloning)
- 5′ sequencing primer pCAGSS-5
- 3′ sequencing primer WPRE-R (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAV2-CAG-3xNLS-vsfGFP-0 was a gift from Murray Blackmore & Pantelis Tsoulfas (Addgene plasmid # 191097 ; http://n2t.net/addgene:191097 ; RRID:Addgene_191097) -
For your References section:
Brain-wide analysis of the supraspinal connectome reveals anatomical correlates to functional recovery after spinal injury. Wang Z, Romanski A, Mehra V, Wang Y, Brannigan M, Campbell BC, Petsko GA, Tsoulfas P, Blackmore MG. Elife. 2022 Jul 15;11. pii: 76254. doi: 10.7554/eLife.76254. 10.7554/eLife.76254 PubMed 35838234